IN2014DN09931A
(th )
2015-08-14
EP2314274A3
(en )
2013-11-13
Compositions comprising a superhydrophilic amphiphilic copolymer and a micellar thickener
WO2017163132A3
(en )
2017-12-14
Use of umbilical cord blood derived exosomes for tissue repair
IN2014DN09928A
(th )
2015-08-14
IN2014DN09937A
(th )
2015-08-14
EP2585084A4
(en )
2014-12-31
MICRONIZED PLAZENTAGE WOVEN COMPOSITIONS AND METHOD FOR THEIR MANUFACTURE AND USE
PH12014502335A1
(en )
2014-12-22
Methods relating to personal care compositions
BR112013004914A2
(pt )
2016-05-03
"composições de pele e métodos de uso das mesmas".
BR112015001608A2
(pt )
2017-07-04
inibidor lfa-1 e polimorfo do mesmo
MX339201B
(es )
2016-05-13
Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
WO2013122932A3
(en )
2014-08-07
Topical use of a skin-commensal prebiotic agent and compositions containing the same
WO2012116081A3
(en )
2014-03-06
Methods for identifying cosmetic agents for skin care compositions
AU2012253759A8
(en )
2013-12-05
Tricyclic sulfonamide compounds and methods of making and using same
WO2013106385A3
(en )
2015-06-18
System and methods for determining tissue elasticity
BR112012014715A2
(pt )
2018-10-09
"processo de tratamento cosmético da pele, e, conjunto cosmético"
WO2011027085A3
(fr )
2011-05-19
Principe actif issu de candida saitoana et utilisation cosmetique pour la detoxification des cellules de la peau
EP2629799A4
(en )
2015-01-21
TOPICAL BASE AND ACTIVE COMPOSITIONS AND PROCESS FOR THE CARE AND TREATMENT OF THE SKIN
BR112012006283A2
(pt )
2016-05-31
formulação de adamts13 estabilizada, método para fabricar uma formulação de adamts13 estabilizada, kit, e métodos para tratar ou prevenir uma doença e para tratar ou previnir um enfarte
MX2013004061A
(es )
2013-07-22
Analogos de ciclosporina.
EP2144590A4
(en )
2013-11-20
SKIN TREATMENT COMPOSITIONS AND METHODS
HK1210953A1
(en )
2016-05-13
Methods for treatment of atherosclerosis
BR112013033339A2
(pt )
2016-08-16
análogos de fluorergolina
UA113962C2
(xx )
2017-04-10
Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
MX2018004616A
(es )
2019-06-20
Cosmetica qie tiene bacterias probioticas.
WO2013006336A3
(en )
2013-04-25
Methods and compositions useful for treating fitzpatrick type iv, v or vi skin